Key facts
- This page summarizes Sarah Taylor Anderson's Form 4 filing for SelectQuote, Inc. (SLQT).
- 13 reported transactions and 7 derivative rows are listed below.
- Accepted by SEC: 04 Aug 2026, 21:16.
Sarah Taylor Anderson - 01 Aug 2026 Form 4 Insider Report for SelectQuote, Inc. (SLQT)
- Reporting relationship
- EVP, Healthcare
- Issuer ticker
- SLQT
- Reported as of
- 01 Aug 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 Aug 2026, 21:16:23 UTC
- Prior SEC filing
- 05 Aug 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Daniel A. Boulware, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Sarah Taylor Anderson filed Form 4 for SelectQuote, Inc. (SLQT) on 04 Aug 2026.
Change
- Previous filing in this sequence was filed on 05 Aug 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001989765
Primary reporting owner
Anderson Sarah Taylor
- Relationship
- EVP, Healthcare
- Address
- 6800 WEST 115TH STREET, SUITE 2511, OVERLAND PARK
- Signature
- /s/ Daniel A. Boulware, Attorney-in-Fact
- Signature date
- 04 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SLQT
transaction
Common Stock, par value $0.01 per share
Options Exercise
- Transaction value
- Shares
- +25,568
- Change %
- +50%
- Price
- $0.000000*
- Shares after
- 77,193
- Date
- 01 Aug 2026
- Ownership
- Direct
SLQT
transaction
Common Stock, par value $0.01 per share
Options Exercise
- Transaction value
- Shares
- +14,561
- Change %
- +19%
- Price
- $0.000000*
- Shares after
- 91,754
- Date
- 01 Aug 2026
- Ownership
- Direct
SLQT
transaction
Common Stock, par value $0.01 per share
Options Exercise
- Transaction value
- Shares
- +37,143
- Change %
- +40%
- Price
- $0.000000*
- Shares after
- 128,897
- Date
- 01 Aug 2026
- Ownership
- Direct
SLQT
transaction
Common Stock, par value $0.01 per share
Options Exercise
- Transaction value
- Shares
- +3,196
- Change %
- +2.5%
- Price
- $0.000000*
- Shares after
- 132,093
- Date
- 01 Aug 2026
- Ownership
- Direct
SLQT
transaction
Common Stock, par value $0.01 per share
Options Exercise
- Transaction value
- Shares
- +4,854
- Change %
- +3.7%
- Price
- $0.000000*
- Shares after
- 136,947
- Date
- 01 Aug 2026
- Ownership
- Direct
SLQT
transaction
Common Stock, par value $0.01 per share
Tax liability
- Transaction value
- Shares
- -24,890
- Change %
- -18%
- Price
- $0.7470*
- Shares after
- 112,057
- Date
- 01 Aug 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SLQT
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -25,568
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 01 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock, par value $0.01 per share
- Underlying amount
- 25,568
- Exercise price
- Footnotes
- F2, F3, F4
SLQT
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -14,561
- Change %
- -50%
- Price
- Shares after
- 14,563
- Date
- 01 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock, par value $0.01 per share
- Underlying amount
- 14,561
- Exercise price
- Footnotes
- F2, F3, F5
SLQT
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -37,143
- Change %
- -33%
- Price
- Shares after
- 74,286
- Date
- 01 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock, par value $0.01 per share
- Underlying amount
- 37,143
- Exercise price
- Footnotes
- F2, F3, F6
SLQT
transaction
Derivative
Price-Vested Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -3,196
- Change %
- -10%
- Price
- Shares after
- 28,762
- Date
- 01 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock, par value $0.01 per share
- Underlying amount
- 3,196
- Exercise price
- Footnotes
- F7, F8, F9
SLQT
transaction
Derivative
Price-Vested Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -4,854
- Change %
- -13%
- Price
- Shares after
- 33,977
- Date
- 01 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock, par value $0.01 per share
- Underlying amount
- 4,854
- Exercise price
- Footnotes
- F7, F8, F10
SLQT
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- Shares
- +77,000
- Change %
- Price
- Shares after
- 77,000
- Date
- 01 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock, par value $0.01 per share
- Underlying amount
- 77,000
- Exercise price
- Footnotes
- F2, F3, F6
SLQT
transaction
Derivative
Price-Vested Restricted Stock Units
Award
- Transaction value
- Shares
- +77,000
- Change %
- Price
- Shares after
- 77,000
- Date
- 01 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock, par value $0.01 per share
- Underlying amount
- 77,000
- Exercise price
- Footnotes
- F7, F8, F11
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 11 footnotes
Footnote F1
Represents shares surrendered to the issuer to satisfy withholding taxes owed upon the vesting of restricted stock units previously granted to the recipient pursuant to the 2020 Omnibus Incentive Plan (the "Plan") of SelectQuote, Inc. (the "Company").
Footnote F2
Represents restricted stock units of the Company granted to the recipient pursuant to the Plan.
Footnote F3
Each restricted stock unit represents a contingent right to receive one share of the Company's common stock, par value $0.01 per share.
Footnote F4
The restricted stock units vest ratably in three annual installments commencing on August 1, 2024, subject to the recipient's continued employment with the Company through the applicable vesting date.
Footnote F5
The restricted stock units vest ratably in three annual installments commencing on August 1, 2025, subject to the recipient's continued employment with the Company through the applicable vesting date.
Footnote F6
The restricted stock units vest ratably in three annual installments commencing on the one-year anniversary of the grant date, subject to the recipient's continued employment with the Company through the applicable vesting date.
Footnote F7
Represents price-vested restricted stock units of the Company ("PVUs") granted to the recipient pursuant to the Plan.
Footnote F8
Each PVU represents the contingent right to receive one share of the Company's common stock, par value $0.01 per share, upon the Company's common stock reaching certain predetermined average trading prices, subject to applicable vesting conditions.
Footnote F9
The PVUs are eligible to vest in three ratable annual installments commencing on August 1, 2024, subject to the recipient's continued employment with the Company through the applicable vesting date. Subject to this vesting schedule, one-fourth of the total number of PVUs granted will vest, if at all, upon the 60-day average closing price of the Company's common stock exceeding each of $2.50, $5.00, $7.50, and $10.00 during the five-year performance period.
Footnote F10
The PVUs are eligible to vest in three ratable annual installments commencing on August 1, 2025, subject to the recipient's continued employment with the Company through the applicable vesting date. Subject to this vesting schedule, one-third of the total number of PVUs granted will vest, if at all, upon the 60-day average closing price of the Company's common stock exceeding each of $3.13, $6.00, and $9.00 during the five-year performance period.
Footnote F11
The PVUs are eligible to vest in three ratable annual installments commencing on the one-year anniversary of the grant date, subject to the recipient's continued employment with the Company through the applicable vesting date. Subject to this vesting schedule, one-third of the total number of PVUs granted will vest, if at all, upon the 60-day average closing price of the Company's common stock exceeding each of $2.00, $3.00, and $4.00 during the five-year performance period.
SEC remarks
EVP, Healthcare